Abstract:Background. A great many patients awaiting liver transplantation die because of the inavailability of donor livers. Liver support systems such as the bioartificial liver have been effective alternatives to ease the shortage. However, the problem with these systems is the difficulty to obtain sufficient amounts of hepatocytes with good liver function. This study explored the possibility of employing a human fetal hepatocyte cell line L-02 for a liver support system. Objective. To confirm the hepatocytic functions of L-02 cells and their potential as a novel cell source to treat acute liver failure (ALF) in a liver support system. Methods. Hepatocyte markers were detected by Western blotting and laser confocal microscopy; their gene expression of hepatic markers was examined by polymerase chain reaction (PCR). An in vivo ALF model was established by 90% partial hepatectomy. Ten rats undergoing hepatectomy received 5 x 10(7) L-02 cells intrasplenically and 15 served as controls. Survival and liver functions were assessed in both groups. Results. In vitro, Western blotting and laser confocal microscopy showed L-02 to express liver function markers: Albumin (ALB), uridine diphosphate glucuronosyltransferase, and cytochrome P450 3A4. PCR showed the expression of liver-specific genes, such as ALB, human glutathione S transferase, and human factor-X. In vivo, rats transplanted with L-02 cells showed significantly improved survival of 70% versus 0% in controls (P < .01). Liver function in the L-02 group was significantly improved versus controls: ALB, 30.2143 +/- 2.68665 versus 25.3 +/- 7.27942 g/L; alanine transaminase, 1611.333 +/- 342.0078 versus 2831.333 +/- 110.437 U/L; aspartate aminotransferase, 2210.667 +/- 97.57732 versus 3149.333 +/- 71.98842 U/L; serum ammonia, 360.4667 +/- 74.94656 versus 660.62 +/- 63.41681 mu mol/L; alkaline phosphates, 408.6667 +/- 48.00347 versus 698.5 +/- 17.67769 U/L; total bilirubin, 29.8 +/- 6.19785 versus 44.6 +/- 9.73858 mu mol/L; and direct bilirubin, 25.4333 +/- 6.60631 versus 32.5 +/- 7.07107 mu mol/L (P < .05). Conclusion. L-02 cells, expressing the main molecules of human hepatocytes, improved liver functions and survival of ALF rats, suggesting them to be a feasible source for liver support systems.

Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model.

A Promising Hepatocyte-Like Cell Line, CCL-13, Exhibits Good Liver Function Both In Vitro and in an Acute Liver Failure Model

Advances in cell sources of hepatocytes for bioartificial liver.

Experimental study of bioartificial liver with cultured human liver cells.

Establishment Of Highly Differentiated Immortalized Human Hepatocyte Line With Simian Virus 40 Large Tumor Antigen For Liver Based Cell Therapy

Transplantation of Monocyte-Derived Hepatocyte-Like Cells (neoheps) Improves Survival in A Model of Acute Liver Failure

Hepatoprotective effect of an immortal human fetal hepatic cell transplantation on CCL(4)-induced acute liver injury in mice.

Effects of Plasma from Acute-on-chronic Liver Failure Patients on Immortalized Human Hepatocytes in Vitro.

Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

Comparison of the Biological Features Between Human Fetal Hepatocyte and Immortalized L-02 Hepatocyte in Vitro

Effects of Plasma from Patients with Acute on Chronic Liver Failure on Function of Cytochrome P450 in Immortalized Human Hepatocytes.

Proliferation of L02 Human Hepatocytes in Tolerized Genetically Immunocompetent Rats

Maintenance of Rat Hepatocytes under Inflammation by Coculture with Human Orbital Fat-Derived Stem Cells

Treatment of Hepatic Failure with Artificial Liver Support System.

Transplantation of Immortalized Human Fetal Hepatocytes Prevents Acute Liver Failure in 90% Hepatectomized Mice.

Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study

Adipose-derived stem cell-based treatment for acute liver failure

Establishment and Characterization of Immortalized Porcine Hepatocytes for the Study of Hepatocyte Xenotransplantation.

Severe Hepatitis Treated with an Artificial Liver Support System

Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers

Repopulation of human L02 hepatocytes in tolerant rats treated with 2-acetaminofluorene